Historical shareholding details of Emerald Mutual Fund Advisers Trust holdings in BridgeBio Pharma Inc (BBIO)

Monthly changes of Emerald Mutual Fund Advisers Trust shareholding in BridgeBio Pharma Inc over the previous months

Month Name Total no. shares held Percent Holding
Mar 31, 2025 Emerald Mutual Fund Advisers Trust 368,282 0.19%
Feb 28, 2025 Emerald Mutual Fund Advisers Trust 368,366 0.19%
Jan 31, 2025 Emerald Mutual Fund Advisers Trust 366,565 0.19%
Dec 31, 2024 Emerald Mutual Fund Advisers Trust 724,872 0.38%
Dec 31, 2024 Emerald Mutual Fund Advisers Trust 319,977 0.17%
Nov 30, 2024 Emerald Mutual Fund Advisers Trust 320,125 0.17%
Oct 31, 2024 Emerald Mutual Fund Advisers Trust 395,705 0.21%
Sep 30, 2024 Emerald Mutual Fund Advisers Trust 751,355 0.40%
Sep 30, 2024 Emerald Mutual Fund Advisers Trust 391,101 0.21%
Aug 31, 2024 Emerald Mutual Fund Advisers Trust 391,101 0.21%
Jul 31, 2024 Emerald Mutual Fund Advisers Trust 242,995 0.13%
Jun 30, 2024 Emerald Mutual Fund Advisers Trust 498,254 0.26%
Jun 30, 2024 Emerald Mutual Fund Advisers Trust 242,995 0.13%
May 31, 2024 Emerald Mutual Fund Advisers Trust 242,995 0.13%
Apr 30, 2024 Emerald Mutual Fund Advisers Trust 242,995 0.13%
Mar 31, 2024 Emerald Mutual Fund Advisers Trust 500,254 0.27%
Mar 31, 2024 Emerald Mutual Fund Advisers Trust 242,995 0.13%
Feb 29, 2024 Emerald Mutual Fund Advisers Trust 242,995 0.14%
Jan 31, 2024 Emerald Mutual Fund Advisers Trust 242,995 0.14%
Dec 31, 2023 Emerald Mutual Fund Advisers Trust 500,254 0.27%
Dec 31, 2023 Emerald Mutual Fund Advisers Trust 242,995 0.14%
Nov 30, 2023 Emerald Mutual Fund Advisers Trust 211,861 0.12%
Oct 31, 2023 Emerald Mutual Fund Advisers Trust 211,861 0.13%
Sep 30, 2023 Emerald Mutual Fund Advisers Trust 500,254 0.29%
Sep 30, 2023 Emerald Mutual Fund Advisers Trust 211,861 0.13%
Aug 31, 2023 Emerald Mutual Fund Advisers Trust 211,861 0.13%
Jul 31, 2023 Emerald Mutual Fund Advisers Trust 211,861 0.13%
Jun 30, 2023 Emerald Mutual Fund Advisers Trust 395,540 0.24%

View all ownership details of BridgeBio Pharma Inc